New heart imaging tool tested in first human study

NCT ID NCT07353710

Not yet recruiting Knowledge-focused Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study will test a new imaging system called CHORUS IDx in 200 people scheduled for a heart ablation procedure. The system takes pictures inside the heart to help doctors see better during the procedure. The main goal is to check if the device is safe and to collect images that will be used to improve the software.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help improve imaging software for guiding heart procedures, potentially making them safer and more effective.
What could go wrong: This is a very early, first-in-human study focused on data collection, not treatment. The device may not work as expected, and there is a risk of procedure-related side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL ARRHYTHMIA INTRACARDIAC ECHOCARDIOGRAPHY

Contacts and locations

Locations

Auckland City Hospital

Auckland, New Zealand
Hygeia Hospital

Athens, Greece
IKEM - Institut klinicke a experimentalni mediciny

Prague, Czechia
Institut Jantung Negara

Kuala Lumpur, Malaysia
Klinicki Bolnicki Centar Split

Split, Croatia
Lingard Private Hospital

Merewether, Australia
National Heart Center Singapore

Singapore, Singapore
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego

Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.